Project purpose
Project
- A comprehensive policy recommendation and workplan, covering the organizational, technical, legal, and ethical aspects required for the tool’s deployment.
- A tailored plan for enhancing the tool’s functionality during outbreaks, where applicable.
- Criteria for verifying the effectiveness of the implementation.
- Financial considerations essential for supporting the decision to implement.
The project will be conducted over 30 months,
running from January 2024 to June 2026
WP3: Mapping
WP3 explores the vaccination strategies employed during the COVID-19 pandemic. Through a scoping review, it aims to identify key practices and the associated public health objectives they address
WP4: Requirements
In Work Package 4, use cases derived from the key practices identified in WP3 will be selected for tool validation. Furthermore, tool specifications will be refined to ensure alignment with national and subnational Member State (MS) policies.
WP5: Implementation plans
In Work Package 5, robust and versatile implementations plan will be developed for each tool, complete with verification criteria
WP6: Pilot Projects
In Work Package 6, fourteen pilot initiatives will be rolled out across seven partner countries to rigorously test the implementation plans for all five categories of tools. Furthermore, these pilot projects will undergo a validation process to ensure they effectively deliver the services they are designed to provide.
WP7: Evaluation
During WP7, the execution of the implementation plans will be critically assessed, and the sustainability of the outcomes will be evaluated.
WP2: MS Uptake & Dissemination
At the core of the project, dissemination efforts (WP2) will focus on distributing communication packages containing implementation plans, along with evidence of their effectiveness and relevance. These efforts will target stakeholders not only within partner countries but also across EC countries and any other regions where they can provide value.”
WP3: Mapping
WP3 explores the vaccination strategies employed during the COVID-19 pandemic. Through a scoping review, it aims to identify key practices and the associated public health objectives they address
WP4: Requirements
In Work Package 4, use cases derived from the key practices identified in WP3 will be selected for tool validation. Furthermore, tool specifications will be refined to ensure alignment with national and subnational Member State (MS) policies.
WP5: Implementation plans
In Work Package 5, robust and versatile implementations plan will be developed for each tool, complete with verification criteria
WP6: Pilot Projects
In Work Package 6, fourteen pilot initiatives will be rolled out across seven partner countries to rigorously test the implementation plans for all five categories of tools. Furthermore, these pilot projects will undergo a validation process to ensure they effectively deliver the services they are designed to provide.
WP7: Evaluation
During WP7, the execution of the implementation plans will be critically assessed, and the sustainability of the outcomes will be evaluated.
WP2: MS Uptake & Dissemination
At the core of the project, dissemination efforts (WP2) will focus on distributing communication packages containing implementation plans, along with evidence of their effectiveness and relevance. These efforts will target stakeholders not only within partner countries but also across EC countries and any other regions where they can provide value.”